Discontinued — last reported Q3 '25
Investing
Investment Proceeds
ResMed Investment Proceeds increased by 900.8% to $2.50M in Q1 2026 compared to the prior quarter.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2020
Last reportedQ3 2025
How to read this metric
An increase suggests the liquidation of assets to raise cash, while a decrease indicates a strategy of holding investments to maturity or reinvesting.
Detailed definition
This metric represents the cash inflows from the sale or maturity of marketable securities and other financial investmen...
Peer comparison
Often mirrors the purchase of investments; peers use these inflows to manage working capital fluctuations or fund strategic initiatives.
Metric ID:
proceeds_from_investmentsHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $1.70M | $1.70M | $1.70M | $1.70M | $0.00 | $0.00 | $250.00K | $0.00 | $0.00 | $750.00K | $4.13M | $250.00K | $0.00 | $250.00K | $0.00 | $250.00K | $2.50M |
| QoQ Change | — | — | +0.0% | +0.0% | +0.0% | -100.0% | — | — | -100.0% | — | — | +450.4% | -93.9% | -100.0% | — | -100.0% | — | +900.8% |
| YoY Change | — | — | — | — | — | -100.0% | -100.0% | — | — | — | — | >999% | — | — | -66.7% | -100.0% | +0.0% | — |
Range$0.00 – $4.13M
Avg YoY Growth+197.4%
Median YoY Growth-83.3%
Current Streak2 quarters growth
Investment Proceeds at Other Companies
Frequently Asked Questions
- What is ResMed's investment proceeds?
- ResMed (RMD) reported investment proceeds of $2.50M in Q1 2026.
- What does investment proceeds mean?
- Cash received from selling or maturing financial investments.